BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
West Pharmaceutical Services recently announced at Pharmapack 2026 in Paris the global commercial availability of its West Synchrony S1 prefillable syringe system, designed to support a wide range of ...
West has launched Synchrony S1, a prefillable syringe system to simplify biologic delivery and combination product needs.
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort to restore pharmaceutical manufacturing and improve domestic supply chains.
FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results